Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Graciela L. Bertocchi"'
Autor:
Melisa D. Castro Eiro, María A. Natale, María G. Alvarez, Araceli Castro, Débora Seigelshifer, Rodolfo Viotti, Marisa Fernández, Luis Mazzuoccolo, Bruno Lococo, Graciela L. Bertocchi, Gonzalo Cesar, María C. Albareda, María J. Elias, María B. Caputo, Eduardo Gaddi, Jeanette Balbaryski, Carlos A. Vigliano, Susana A. Laucella
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 4 (2022)
ABSTRACT Dermatitis is the most common adverse event during treatment with benznidazole in chronic Chagas disease and is probably mediated by T cells. A set of molecules representative of the different type IV hypersensitivity reactions was evaluated
Externí odkaz:
https://doaj.org/article/fc9cdf3b60b54221970e33aec034c6a1
Autor:
Melisa D. Castro Eiro, María G. Alvarez, Gretchen Cooley, Rodolfo J. Viotti, Graciela L. Bertocchi, Bruno Lococo, María C. Albareda, Ana M. De Rissio, María A. Natale, Cecilia Parodi, Rick L. Tarleton, Susana A. Laucella
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
BackgroundSubjects are considered infected with Trypanosoma cruzi when tested positive by at least two out of three serological tests, whereas a positive result in only one of up to three tests is termed “serodiscordant” (SD). Assessment of paras
Externí odkaz:
https://doaj.org/article/67683899e7df439d8b420b56b1474370
Autor:
María G Alvarez, Graciela L Bertocchi, Gretchen Cooley, María C Albareda, Rodolfo Viotti, Damián E Perez-Mazliah, Bruno Lococo, Melisa Castro Eiro, Susana A Laucella, Rick L Tarleton
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 4, p e0004657 (2016)
BACKGROUND:Chagas disease is the highest impact parasitic disease in Latin America. We have proposed that changes in Trypanosoma cruzi-specific immune responses might serve as surrogate indicators of treatment success. Herein, we addressed in a long-
Externí odkaz:
https://doaj.org/article/564060fe26f548f9afa73f29c5fdbd37
Autor:
María C. Albareda, Miriam Postan, Marcos Petti, Bruno Lococo, Rodolfo J. Viotti, Alejandro Armenti, Damián Pérez, María G. Álvarez, Graciela L. Bertocchi, Susana A. Laucella, Rick L. Tarleton
Publikováno v:
Revista Argentina de Cardiología, Vol 76, Iss 4, Pp 260-265 (2008)
Para determinar el efecto del tratamiento con benznidazol sobre las células T de memoria específica para Trypanosoma cruzi, se seleccionaron 47 pacientes con tres reacciones serológicas positivas para T. cruzi, sin cardiopatía y edades comprendid